BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29798751)

  • 1. [Ano-genital warts are more than benign lesions].
    Larsen HK; Kofoed K
    Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29798751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
    Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I
    J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of genitals warts in pre-HPV vaccine era after laser treatment.
    Widschwendter A; Böttcher B; Riedl D; Coban S; Mutz-Dehbalaie I; Matteucci Gothe R; Ciresa-König A; Marth C; Fessler S
    Arch Gynecol Obstet; 2019 Sep; 300(3):661-668. PubMed ID: 31286210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital warts.
    Dupin N
    Clin Dermatol; 2004; 22(6):481-6. PubMed ID: 15596319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genital warts and HPV vaccination].
    Pilka R; Dvorák V; Fait T
    Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are anogenital warts diagnoses decreasing in the U.K.: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?
    Clarke E; Board C; Patel N; Atkinson L; Tulloch H; Patel R
    Sex Transm Infect; 2014 Dec; 90(8):587. PubMed ID: 25398729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
    Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
    Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
    Canvin M; Sinka K; Hughes G; Mesher D
    Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.
    Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ
    J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.
    Forcier M; Musacchio N
    Dermatol Ther; 2010; 23(5):458-76. PubMed ID: 20868401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT
    Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital warts.
    Steben M; Garland SM
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1063-73. PubMed ID: 25155525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus, genital warts, and vaccines.
    Hsueh PR
    J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV vaccination in boys and men.
    Stanley M
    Hum Vaccin Immunother; 2014; 10(7):2109-11. PubMed ID: 25424825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.